These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

82 related articles for article (PubMed ID: 3103344)

  • 21. [The safety and efficacy of systemic salvage thrombolysis in acute myocardial infarct].
    Sarullo FM; Schicchi R; Schirò M; Americo L; Bonnì G; Faraone N; Di Pasquale P; Castello A; Mauri F
    Ital Heart J Suppl; 2000 Jan; 1(1):81-7. PubMed ID: 10832123
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [The absence of a procoagulant effect after TNK-t-PA: a comparison with streptokinase and rt-PA].
    De Marco E; Andreotti F; van de Greef W; Quaranta G; Biasucci LM; Kol A; Maseri A; Rebuzzi AG
    Cardiologia; 1998 Nov; 43(11):1209-13. PubMed ID: 9922587
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Outcome of different reperfusion strategies in patients with former contraindications to thrombolytic therapy: a comparison of primary angioplasty and tissue plasminogen activator. Primary Angioplasty in Myocardial Infarction (PAMI) Investigators.
    Stone GW; Grines CL; Browne KF; Marco J; Rothbaum D; O'Keefe JH; Hartzler GO; Overlie P; Donohue B; Chelliah N; Vlietstra R; Puchrowicz-Ochocki S; O'Neill WW
    Cathet Cardiovasc Diagn; 1996 Dec; 39(4):333-9. PubMed ID: 8958418
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Prospects of thrombolytic therapy for acute ischemic stroke].
    Nakashima T; Minematsu K
    Brain Nerve; 2009 Sep; 61(9):1003-12. PubMed ID: 19803399
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Role of the clinical laboratory in monitoring fibrinolytic therapy of acute myocardial infarction.
    Bovill E; Triplett D; Stump D
    Hematol Pathol; 1990; 4(2):61-6. PubMed ID: 2115512
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Thrombolysis in Myocardial Infarction (TIMI) Trial, Phase I: A comparison between intravenous tissue plasminogen activator and intravenous streptokinase. Clinical findings through hospital discharge.
    Chesebro JH; Knatterud G; Roberts R; Borer J; Cohen LS; Dalen J; Dodge HT; Francis CK; Hillis D; Ludbrook P
    Circulation; 1987 Jul; 76(1):142-54. PubMed ID: 3109764
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The thrombolysis in myocardial infarction (TIMI) trial phase I and phase IIA pilot results. Implications for nursing.
    Brewer-Senerchia C
    Prog Cardiovasc Nurs; 1988; 3(4):128-36. PubMed ID: 2974593
    [No Abstract]   [Full Text] [Related]  

  • 28. Thrombolysis in Myocardial Infarction (TIMI) Trial--phase I: hemorrhagic manifestations and changes in plasma fibrinogen and the fibrinolytic system in patients treated with recombinant tissue plasminogen activator and streptokinase.
    Rao AK; Pratt C; Berke A; Jaffe A; Ockene I; Schreiber TL; Bell WR; Knatterud G; Robertson TL; Terrin ML
    J Am Coll Cardiol; 1988 Jan; 11(1):1-11. PubMed ID: 3121710
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Thrombolysis with intravenous human recombinant tissue-type plasminogen activator in acute myocardial infarction: the European experience.
    de Bono DP
    J Am Coll Cardiol; 1987 Nov; 10(5 Suppl B):75B-78B. PubMed ID: 2959717
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Coronary thrombolysis: streptokinase or recombinant tissue-type plasminogen activator?
    Collen D
    Ann Intern Med; 1990 Apr; 112(7):529-38. PubMed ID: 2107781
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The effect of intravenous thrombolytic therapy on left ventricular function: a report on tissue-type plasminogen activator and streptokinase from the Thrombolysis in Myocardial Infarction (TIMI Phase I) trial.
    Sheehan FH; Braunwald E; Canner P; Dodge HT; Gore J; Van Natta P; Passamani ER; Williams DO; Zaret B
    Circulation; 1987 Apr; 75(4):817-29. PubMed ID: 3103950
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Use of fibrinolytics in the treatment of acute myocardial infarction in Denmark. A questionnaire study].
    Nielsen JD; Stoltenberg M; Siemsen M; Juul A; Pedersen F; Madsen JK
    Ugeskr Laeger; 1990 Aug; 152(33):2368-70. PubMed ID: 2120830
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Recombinant tissue plasminogen activator (rt-PA): is it the thrombolytic agent of choice for an evolving acute myocardial infarction?
    Sherry S
    Am J Cardiol; 1987 Apr; 59(9):984-9. PubMed ID: 3105303
    [No Abstract]   [Full Text] [Related]  

  • 34. Findings on the efficacy and safety of thrombolytic therapy. An analysis of key clinical trials.
    Ventura B
    Crit Care Nurs Clin North Am; 1990 Dec; 2(4):663-71. PubMed ID: 2096871
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The European Cooperative Study Group trial of intravenous recombinant tissue-type plasminogen activator (rt-PA) and conservative therapy versus rt-PA and immediate coronary angioplasty.
    de Bono DP
    J Am Coll Cardiol; 1988 Dec; 12(6 Suppl A):20A-23A. PubMed ID: 2973485
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Safety and efficacy of tissue-type plasminogen activator produced by recombinant DNA technology.
    Sobel BE
    J Am Coll Cardiol; 1987 Nov; 10(5 Suppl B):40B-44B. PubMed ID: 3117860
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Residual coronary stenosis after thrombolysis with rt-PA or streptokinase: acute results and 3 weeks follow-up.
    Schmidt WG; Uebis R; von Essen R; Effert S; Erbel R; Meyer J; Rutsch W; Schartl M; Schmutzler H
    Eur Heart J; 1987 Nov; 8(11):1182-8. PubMed ID: 3121335
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Thrombolytic therapy in acute myocardial infarction: Part II--rt-PA.
    Mueller HS; Roberts R; Teichman SL; Sobel BE
    Med Clin North Am; 1989 Mar; 73(2):387-407. PubMed ID: 2493116
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Thrombolysis in myocardial infarction (TIMI): comparative studies of coronary reperfusion and systemic fibrinogenolysis with two forms of recombinant tissue-type plasminogen activator.
    Mueller HS; Rao AK; Forman SA
    J Am Coll Cardiol; 1987 Sep; 10(3):479-90. PubMed ID: 3114349
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Bolus, front-loaded, and accelerated thrombolytic infusions for myocardial infarction and pulmonary embolism.
    Levine MN
    Chest; 1991 Apr; 99(4 Suppl):128S-134S. PubMed ID: 2009809
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.